JAK1 and non-small cell lung carcinoma: In accordance with our in silico analyses, in vitro studies demonstrated that CRE treatment significantly suppressed the expression level (relative protein expression) of SRC, STAT3, PIK3CA, MAPK1, EGFR, and JAK1 in PC-13 NSCLC cells.